Hyperprolactinaemia in primary Sjogren's syndrome [1]

Prolactin (PRL) is a neuroendocrine hormone that has important immunoregulatory properties. It is a potent mitogen in Nb2 T lymphoma cell line and stimulates both T-cell mediated and humoral immunity.' Recently an association between hyperprolactinaemia and certain rheumatic diseases has been d...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
1994
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/28453
Acceso en línea:
http://dx.doi.org/10.1136/ard.53.6.425-a
https://repository.urosario.edu.co/handle/10336/28453
Palabra clave:
Hyperprolactinaemia
Primary Sjogren's syndrome
Rights
License
Abierto (Texto Completo)
id EDOCUR2_0310bcfa84886d990d59aaa651eb1042
oai_identifier_str oai:repository.urosario.edu.co:10336/28453
network_acronym_str EDOCUR2
network_name_str Repositorio EdocUR - U. Rosario
repository_id_str
spelling 3087f619-dc20-45cb-bea9-a311c04d367019474778600f5b7493a-694e-4bad-918b-6c7454c06f7db8df2593-0af2-42eb-81ec-65f6561e02f86e1eca80-8f45-4be2-a02c-b9dd9c23563c9734735a-713f-4d76-b8d4-0a5b87d6e8652020-08-28T15:48:14Z2020-08-28T15:48:14Z1994-01-01Prolactin (PRL) is a neuroendocrine hormone that has important immunoregulatory properties. It is a potent mitogen in Nb2 T lymphoma cell line and stimulates both T-cell mediated and humoral immunity.' Recently an association between hyperprolactinaemia and certain rheumatic diseases has been described suggesting that PRL may play a role in the pathogenesis of some autoimmune diseases.94 In addition, PRL seems to be an autocrine factor required for viability and proliferation of B lymphoma cells.5 Furthermore, it was recently proposed that hyperprolactinaemia observed in oestrogentreated mice may predispose to development of lymphoma in these animals.6 Primary Sj6gren's syndrome (P-SS) is a chronic autoimmune disease characterised by exocrine glandular insufficiency secondary to lymphocytic and plasma cell infiltration. The spectrum of the disease extends from an organ specific autoimmune disease to a systemic involvement.7 Characteristically, patients with Sjogren's syndrome (SS) have an increased risk of developing lymphoma.'application/pdfhttp://dx.doi.org/10.1136/ard.53.6.425-aISSN: 0003-4967EISSN: 1468-2060https://repository.urosario.edu.co/handle/10336/28453engBMJ Publishing Group428No. 53425Annals of the Rheumatic DiseasesAnnals of the Rheumatic Diseases, ISSN: 0003-4967; EISSN: 1468-2060, No.53 (June, 1994); pp. 425-428https://ard.bmj.com/content/53/6/425.1Abierto (Texto Completo)http://purl.org/coar/access_right/c_abf2Annals of the Rheumatic Diseasesinstname:Universidad del Rosarioreponame:Repositorio Institucional EdocURHyperprolactinaemiaPrimary Sjogren's syndromeHyperprolactinaemia in primary Sjogren's syndrome [1]Hiperprolactinemia en el síndrome de Sjogren primario [1]articleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Gutiérrez, M.A.Anaya, Juan-ManuelScopelitis E.Citera, G.Silveira, L. H.Espinoza, L.10336/28453oai:repository.urosario.edu.co:10336/284532021-08-10 21:44:48.495https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co
dc.title.spa.fl_str_mv Hyperprolactinaemia in primary Sjogren's syndrome [1]
dc.title.TranslatedTitle.spa.fl_str_mv Hiperprolactinemia en el síndrome de Sjogren primario [1]
title Hyperprolactinaemia in primary Sjogren's syndrome [1]
spellingShingle Hyperprolactinaemia in primary Sjogren's syndrome [1]
Hyperprolactinaemia
Primary Sjogren's syndrome
title_short Hyperprolactinaemia in primary Sjogren's syndrome [1]
title_full Hyperprolactinaemia in primary Sjogren's syndrome [1]
title_fullStr Hyperprolactinaemia in primary Sjogren's syndrome [1]
title_full_unstemmed Hyperprolactinaemia in primary Sjogren's syndrome [1]
title_sort Hyperprolactinaemia in primary Sjogren's syndrome [1]
dc.subject.keyword.spa.fl_str_mv Hyperprolactinaemia
Primary Sjogren's syndrome
topic Hyperprolactinaemia
Primary Sjogren's syndrome
description Prolactin (PRL) is a neuroendocrine hormone that has important immunoregulatory properties. It is a potent mitogen in Nb2 T lymphoma cell line and stimulates both T-cell mediated and humoral immunity.' Recently an association between hyperprolactinaemia and certain rheumatic diseases has been described suggesting that PRL may play a role in the pathogenesis of some autoimmune diseases.94 In addition, PRL seems to be an autocrine factor required for viability and proliferation of B lymphoma cells.5 Furthermore, it was recently proposed that hyperprolactinaemia observed in oestrogentreated mice may predispose to development of lymphoma in these animals.6 Primary Sj6gren's syndrome (P-SS) is a chronic autoimmune disease characterised by exocrine glandular insufficiency secondary to lymphocytic and plasma cell infiltration. The spectrum of the disease extends from an organ specific autoimmune disease to a systemic involvement.7 Characteristically, patients with Sjogren's syndrome (SS) have an increased risk of developing lymphoma.'
publishDate 1994
dc.date.created.spa.fl_str_mv 1994-01-01
dc.date.accessioned.none.fl_str_mv 2020-08-28T15:48:14Z
dc.date.available.none.fl_str_mv 2020-08-28T15:48:14Z
dc.type.eng.fl_str_mv article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.spa.spa.fl_str_mv Artículo
dc.identifier.doi.none.fl_str_mv http://dx.doi.org/10.1136/ard.53.6.425-a
dc.identifier.issn.none.fl_str_mv ISSN: 0003-4967
EISSN: 1468-2060
dc.identifier.uri.none.fl_str_mv https://repository.urosario.edu.co/handle/10336/28453
url http://dx.doi.org/10.1136/ard.53.6.425-a
https://repository.urosario.edu.co/handle/10336/28453
identifier_str_mv ISSN: 0003-4967
EISSN: 1468-2060
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.citationEndPage.none.fl_str_mv 428
dc.relation.citationIssue.none.fl_str_mv No. 53
dc.relation.citationStartPage.none.fl_str_mv 425
dc.relation.citationTitle.none.fl_str_mv Annals of the Rheumatic Diseases
dc.relation.ispartof.spa.fl_str_mv Annals of the Rheumatic Diseases, ISSN: 0003-4967; EISSN: 1468-2060, No.53 (June, 1994); pp. 425-428
dc.relation.uri.spa.fl_str_mv https://ard.bmj.com/content/53/6/425.1
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.acceso.spa.fl_str_mv Abierto (Texto Completo)
rights_invalid_str_mv Abierto (Texto Completo)
http://purl.org/coar/access_right/c_abf2
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv BMJ Publishing Group
dc.source.spa.fl_str_mv Annals of the Rheumatic Diseases
institution Universidad del Rosario
dc.source.instname.none.fl_str_mv instname:Universidad del Rosario
dc.source.reponame.none.fl_str_mv reponame:Repositorio Institucional EdocUR
repository.name.fl_str_mv Repositorio institucional EdocUR
repository.mail.fl_str_mv edocur@urosario.edu.co
_version_ 1814167713312931840